Company Long-Term Loans and Borrowings: Organovo Holdings Inc (ONVO)

Public company logo of Organovo Holdings Inc (ONVO)

The market trend for Organovo Holdings, Inc. (ONVO) shares on GURU.Markets is recorded at 0.00. Organovo Holdings, Inc. (ONVO) creates a 3D bioprinting environment, helping drug developers minimize errors before trials begin. The production cycle relies on California centers with duplicated precision equipment. The biotech's current success is tied to the effectiveness of combating liver fibrosis and the influx of investment into scientific research.

ONVO Organovo Holdings, Inc. Company Long-Term Debts (07/04/2022 - 04/24/2025)

Summary analytical data breakdowns for Organovo Holdings Inc (ONVO)

- market price and analyst price targets:
Stock Price organovo.com|ONVO - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Organovo|ONVO - Total Company Value
- book capitalization information:
Accounting Value per Share Organovo|ONVO - Book Capitalization|Market Capitalization to Book Value Ratio organovo.com|ONVO - Cumulative Company Assets
- debt level and financial liquidity data:
All Debt to Shareholders' Equity Ratio Organovo Holdings, Inc.|ONVO - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Organovo Corp|ONVO - Company Aggregate Debts|Debts to Book Value Organovo|ONVO - Company Long-Term Liabilities|Amount of Current Liabilities Organovo|Quick Ratio organovo.com
- earnings and multiples data:
ONVO - Net Profit
Summary company analytics:Organovo Holdings, Inc.
Brand item of Organovo Holdings, Inc.

For Organovo Holdings, Inc. (ONVO), long-term liabilities serve as a survival tool amid the costly development of 3D bioprinting. This metric aggregates all loans and borrowings with maturities exceeding one year, determining the overall debt load. By analyzing the business's long-term borrowed capital, an investor assesses the stability of the balance sheet structure. The upward trend reflects a search for external financing to cover operational deficits, signaling the company's high dependence on borrowed funds.

Competitor analysis for Organovo Holdings, Inc.

Company Long-Term Debts ascendispharma.com ASND|MDGL - Company Long-Term Debt|Company Long-Term Loans and Borrowings CORT (Corcept Therapeutics Inc.)|Rhythm Pharmaceuticals Inc (RYTM) - Company Long-Term Debt|Company Long-Term Liabilities Akero Corp|MTSR (Metsera Inc) - Company Long-Term Debts|Company Long-Term Debts moonlaketx.com|Company Long-Term Liabilities CRNX (Crinetics)|NAMS (NewAmsterdam Pharma Company) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Soleno SLNO|FOLD - Company Long-Term Liabilities|89bio, Inc. - Company Long-Term Debts|Long-Term Debt agios.com|GPCR (Structure Therapeutics Inc.) - Company Long-Term Liabilities|MDXG: Amount of Long-Term Liabilities|RZLT (Rezolute Corp) - Company Long-Term Debts|Company Long-Term Debts Lexicon Corp|Company Long-Term Debts MBX|Company Long-Term Debt ALT (altimmune.com)|Company Long-Term Debt Aardvark Therapeutics AARD|Sagimet Biosciences, Inc. (SGMT) - Long-Term Debt|BIOA - Company Long-Term Debt|BMEA: Company Long-Term Debt|QNCX: Company Long-Term Debts|GUTS - Long-Term Debt Volume|Company Long-Term Debt vTv Therapeutics, Inc.|Agape ATP Corp. (ATPC) - Long-Term Debt Volume|Company Long-Term Debt Pluri Inc. (PLUR)|Company Long-Term Liabilities synlogictx.com SYBX|Company Long-Term Debt Lipocine Inc. LPCN|Matinas BioPharma Holdings, Inc. (MTNB) - Long-Term Debt|SPRB - Company Long-Term Debt|Company Long-Term Loans and Borrowings GLTO (Galecto Inc)|CTCX: Company Long-Term Debts|Long-Term Indebtedness Lumos Therapeutics LUMO|RDUS (Radius Recycling, Inc.) - Company Long-Term Debts